Skip to main content
Premium Trial:

Request an Annual Quote

NIH Awards TriLink $130K to Develop RNA Sample Prep Method for NGS

NEW YORK (GenomeWeb News) – TriLink BioTechnologies today announced a $130,000 award from the National Institutes of Health to develop a sample preparation method for next-generation sequencing.

The San Diego-based firm will use its expertise in nucleic acid chemistry as part of the Phase I Small Business Innovation Research grant to develop an approach to RNA sample prep, it said. The grant last through July.

TriLink will investigate methods of reducing the formation of adapters dimers during RNA sample prep, which would eliminate the need for gel purification prior to sequencing.

"Improving the process of RNA sample preparation for next generation sequencing will increase the accessibility of this valuable tool," Richard Hogrefe, CEO of TriLink, said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more